IRIS
PAPPONE, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.898
NA - Nord America 8.875
EU - Europa 8.274
SA - Sud America 2.933
Continente sconosciuto - Info sul continente non disponibili 639
AF - Africa 247
OC - Oceania 6
Totale 29.872
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.398
RU - Federazione Russa 4.877
SG - Singapore 3.340
CN - Cina 2.531
BR - Brasile 2.372
HK - Hong Kong 1.089
VN - Vietnam 964
SE - Svezia 956
IT - Italia 570
FR - Francia 437
DE - Germania 281
RO - Romania 270
IE - Irlanda 225
FI - Finlandia 204
AR - Argentina 201
IN - India 184
BD - Bangladesh 175
CA - Canada 172
GB - Regno Unito 158
ID - Indonesia 115
MX - Messico 113
EC - Ecuador 94
IQ - Iraq 84
CO - Colombia 78
ZA - Sudafrica 74
AT - Austria 58
TR - Turchia 49
VE - Venezuela 47
NL - Olanda 46
PK - Pakistan 46
PL - Polonia 42
PY - Paraguay 42
JP - Giappone 40
JM - Giamaica 38
UZ - Uzbekistan 37
MA - Marocco 36
CL - Cile 34
CR - Costa Rica 34
SA - Arabia Saudita 34
UA - Ucraina 26
UY - Uruguay 26
ES - Italia 25
TN - Tunisia 24
HN - Honduras 23
DZ - Algeria 22
KE - Kenya 22
PE - Perù 22
PH - Filippine 22
LT - Lituania 21
MD - Moldavia 21
NP - Nepal 19
EG - Egitto 18
MY - Malesia 18
NI - Nicaragua 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 16
TT - Trinidad e Tobago 16
BO - Bolivia 15
DO - Repubblica Dominicana 14
JO - Giordania 14
OM - Oman 14
KZ - Kazakistan 13
EU - Europa 12
GT - Guatemala 9
PT - Portogallo 9
SN - Senegal 9
IR - Iran 8
LB - Libano 8
SV - El Salvador 8
AL - Albania 7
BE - Belgio 7
ET - Etiopia 7
BB - Barbados 6
LY - Libia 6
QA - Qatar 6
AM - Armenia 5
BZ - Belize 5
GE - Georgia 5
KR - Corea 5
KW - Kuwait 5
NG - Nigeria 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
IL - Israele 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AU - Australia 3
BG - Bulgaria 3
CD - Congo 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
DM - Dominica 3
KG - Kirghizistan 3
KH - Cambogia 3
LV - Lettonia 3
NO - Norvegia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
Totale 29.186
Salva come PNG Salva come JPEG
Città #
Dallas 2.250
Singapore 1.271
Hong Kong 1.076
Moscow 1.018
San Jose 857
Ashburn 661
Council Bluffs 520
Shanghai 475
Hefei 459
Lawrence 431
Princeton 427
Ho Chi Minh City 395
Lauterbourg 386
Dublin 225
São Paulo 190
Hanoi 189
Beijing 178
Helsinki 171
Santa Clara 171
New York 159
Milan 141
Phoenix 105
Los Angeles 104
Rio de Janeiro 73
Nuremberg 64
Orem 62
Boardman 53
Atlanta 52
Brasília 45
Rome 45
Brooklyn 44
Curitiba 44
Chicago 43
Belo Horizonte 42
Da Nang 42
Haiphong 42
Munich 42
Chennai 40
Denver 39
Porto Alegre 38
Johannesburg 37
Warsaw 37
Baghdad 36
Toronto 35
Guangzhou 34
London 34
Seattle 34
Tashkent 33
Tianjin 33
Tokyo 33
Boston 32
Guayaquil 32
Salvador 32
Washington 32
Frankfurt am Main 31
Campinas 28
Houston 28
Montreal 28
Manchester 27
San José 27
Stockholm 26
Pune 25
Vienna 25
Biên Hòa 24
Quito 24
Amsterdam 23
Buenos Aires 23
Hangzhou 23
Las Vegas 23
Poplar 23
Philadelphia 22
Dhaka 21
Montevideo 21
Jakarta 20
Nairobi 20
San Francisco 20
Asunción 19
Caxias do Sul 19
Goiânia 19
Kingston 19
Santo André 19
Caracas 18
Guarulhos 18
Hải Dương 18
Mumbai 18
Osasco 18
Ribeirão Preto 18
Managua 17
Mexico City 17
Recife 17
Thái Nguyên 17
Ankara 16
Bogotá 16
Fortaleza 16
Lappeenranta 16
Queens 16
Shenzhen 16
Sorocaba 16
Turku 16
Baku 15
Totale 14.089
Salva come PNG Salva come JPEG
Nome #
1. Cardiac Resynchronization Therapy with Multisite Left Ventricular Pacing Improves Acute Hemodynamic Response in Patients 1.429
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction 240
A 20-joule electrical cardioversion applied directly to the heart elevates troponin I by at least 1.5 ng.mL(-1) 152
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 149
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 145
A Brugada Syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 142
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 138
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society 137
Ablation catheter with flexible tip and methods of making the same 134
A controlled randomized trial of biatrial ablation for curing long-lasting permanent atrial fibrillation (the Decomplex Trial) 132
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 130
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 128
Brugada syndrome genetics is associated with phenotype severity 128
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 127
65. Cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure early multicenter experience 127
A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White Syndrome 122
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 121
A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach 119
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 116
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 116
Brugada Syndrome: Warning of a Systemic Condition? 115
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 115
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 113
[A methodological approach to the transcatheter radiofrequency ablation of anomalous Kent-type pathways] 113
[The physical and chemical principles of radiofrequency catheter ablation in arrhythmias] 113
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 111
“How to Perform Circumferential Pulmonary Vein Ablation with Electroanatomical Guidance” 109
[Atrioventricular conduction before and after the radiofrequency catheter ablation of a nodal reentry tachycardia circuit] 109
Calcium in Brugada syndrome: Questions for future research 109
[Ablation of paroxysmal tachycardia in Wolff-Parkinson-White syndrome] 108
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 107
“How to implant biventricular pacemakers in patients with heart failure” (basics and advanced techniques 106
“Cardiac Resynchronization Therapy” 105
“Theory and Practice of Catheter Ablation of Atrial Fibrillation. Seven different cases” 105
A randomized study of prophyl actic catheter ablation in high-risk children with asymptomatic Wolff-Parkinson-White syndrome 105
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 105
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study 104
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 103
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 101
[Prospects of the treatment of atrial fibrillation. Circumferential radiofrequency ablation of pulmonary vein ostia] 101
[Radiofrequency catheter ablation of atrial tachycardia: technique, results and follow-up] 101
HIF-1α Directly Controls WNT7A Expression During Myogenesis 101
The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction 101
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 100
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 96
“Stroke Prevention: Left Atrial Appendage Occlusion” 95
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate 94
Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation 93
Dynamic programming of atrioventricular delay improves electrical synchrony in a multicenter cardiac resynchronization therapy study 91
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 89
“Circumferential Pulmonary Vein Ablation With MediGuide® System” 89
Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Meta-Analysis of Quality of Life, Morbidity, and Mortality 89
Brugada Syndrome: Oligogenic or Mendelian Disease? 89
“Management of Advanced Atrial Fibrillation” 88
Case Report: Efficacy of Rituximab in a Patient With Familial Mediterranean Fever and Multiple Sclerosis 88
Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis 87
Course Syllabus: “Theory and Practice of Catheter Ablation of Atrial Fibrillation 2002” 87
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 87
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 87
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 85
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 84
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA) 84
Antitachycardia devices for the treatment of recurrent ventricular tachycardia: long term results 83
Sphingolipid synthesis inhibition by myriocin administration enhances lipid consumption and ameliorates lipid response to myocardial ischemia reperfusion injury 83
Stereotaxis “Atrial Fibrillation Ablation” 82
Follow-up of a respiratory rate modulated pacemaker 82
Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique results from a prospective randomized trial 82
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 82
The APAF study: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial [Die APAF-studie: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial] 81
Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: A multicentre registry 81
Deep learning unmasks the ECG signature of Brugada syndrome 80
Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation 80
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 80
Prospective European survey on atrial fibrillation ablation: Clinical characteristics of patients and ablation strategies used in different countries 80
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 79
Management of severe cardiac arrhythmic events in elite athletes 79
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 79
Atrial fibrillation progression and management: a 5-year prospective follow-up study 79
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 79
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 79
Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site 78
Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram 78
Novel JAG1 deletion variant in patient with atypical alagille syndrome 78
Regenerating the human heart : direct reprogramming strategies and their current limitations 77
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen 77
Nanobodies Counteract the Toxicity an Amyloidogenic Light Chain by Stabilizing a Partially Open Dimeric Conformation 76
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 75
Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome 74
Electrocardiographic temporo-spatial assessment of depolarization and repolarization changes after epicardial arrhythmogenic substrate ablation in Brugada syndrome 73
Fibroma of the left ventricle in a patient with Sotos syndrome 73
Atrial fibrillation in elite athletes 73
Wolff-parkinson-white syndrome in the era of catheter ablation insights from a registry study of 2169 patients 73
Circumferential pulmonary-vein ablation for chronic atrial fibrillation 72
Quantitative assessment of left ventricular contractile synchrony during biventricular pacing using color kinesis echocardiography 72
Primary atrial tachycardia: techniques for intracardiac mapping and radiofrequency ablation 72
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 72
Epicardial ablation of atrial fibrillation during heart valve surgery 71
Cardiac magnetic resonance with implanted monitor 71
Epicardial arrhythmogenic substrate in long QT syndrome 70
Efficacy of radiofrequency catheter ablation of accessory pathway in patients with previous unsuccessful surgical ablation 70
Totale 11.119
Salva come PNG Salva come JPEG
Categoria #
all - tutte 194.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 194.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022173 0 0 0 90 8 9 19 3 22 2 13 7
2022/20232.257 1.071 444 106 18 6 180 223 76 83 32 14 4
2023/2024563 39 23 59 78 39 69 14 57 0 28 38 119
2024/20255.661 834 79 26 77 121 387 824 454 1.149 896 373 441
2025/202617.981 1.066 1.662 2.525 2.910 1.037 476 1.274 1.081 4.313 968 365 304
2026/20272.810 543 1.163 963 141 0 0 0 0 0 0 0 0
Totale 29.872